The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(1-(2-hydroxy-4-methylphenyl)propylidene)-2-((2-morpholinoethyl)amino)isonicotinohydrazide ID: ALA5278135
Max Phase: Preclinical
Molecular Formula: C22H29N5O3
Molecular Weight: 411.51
Associated Items:
Names and Identifiers Canonical SMILES: CC/C(=N/NC(=O)c1ccnc(NCCN2CCOCC2)c1)c1ccc(C)cc1O
Standard InChI: InChI=1S/C22H29N5O3/c1-3-19(18-5-4-16(2)14-20(18)28)25-26-22(29)17-6-7-23-21(15-17)24-8-9-27-10-12-30-13-11-27/h4-7,14-15,28H,3,8-13H2,1-2H3,(H,23,24)(H,26,29)/b25-19-
Standard InChI Key: VCUABTLJNPWFFN-PLRJNAJWSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
-0.7113 1.8472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7113 1.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0019 0.6158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7090 1.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7090 1.8476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0001 2.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0001 3.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4206 0.6151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0019 -0.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7136 -0.6165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4251 -0.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7096 -0.6165 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4212 -0.2057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1328 -0.6165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8444 -0.2057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1328 -1.4383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4221 -1.8493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4221 -2.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1338 -3.0795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8475 -2.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8475 -1.8508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7104 -3.0794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0011 -2.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7127 -3.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4243 -2.6685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4243 -1.8469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1359 -1.4360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8475 -1.8469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8475 -2.6686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1359 -3.0794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
6 7 1 0
4 8 1 0
3 9 1 0
9 10 1 0
10 11 1 0
9 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
14 16 1 0
17 16 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
16 21 1 0
18 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
26 25 1 0
27 26 1 0
28 27 1 0
29 28 1 0
30 29 1 0
25 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 411.51Molecular Weight (Monoisotopic): 411.2270AlogP: 2.38#Rotatable Bonds: 8Polar Surface Area: 99.08Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.76CX Basic pKa: 6.37CX LogP: 2.37CX LogD: 2.31Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: -1.56
References 1. Phull MS, Jadav SS, Gundla R, Mainkar PS.. (2021) A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors., 212 [PMID:33445154 ] [10.1016/j.ejmech.2020.113149 ]